We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Otsuka Sues Apotex Again Over Generic Abilify

Law360 (October 23, 2008, 12:00 AM EDT) -- Japanese drugmaker Otsuka Pharmaceutical Co. Ltd. has slapped Apotex Inc. with a new lawsuit over Apotex's request to make yet another dosage of a generic version of Otsuka's schizophrenia drug Abilify, even as the companies spar over a key patent for the drug in a different action.

Otsuka filed an amended complaint against Apotex on Wednesday in the U.S. District Court for the District of New Jersey in response to the news that Apotex was seeking to expand its abbreviated new drug application for a generic...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.